Comparison of therapeutic efficacy of lipo-doxorubicin and doxorubicin in treating bladder cancer

Our study demonstrated that Lipodox can enhance doxorubicin cytotoxicity in bladder cancer cells and inhibit tumor growth in orthotopic bladder cancer with improved survival rate. Therefore, we suggest Lipodox may act as an alternative to doxorubicin in the treatment of local bladder cancer.